Grand Angels
26
5M
19
1.37
3
0.27
3
- Stages of investment
- Areas of investment
Summary
In 2004 was created Grand Angels, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Holland.
Among the most popular fund investment industries, there are Pharmaceutical, Life Science. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight HistoSonics, Ambiq Micro, AzulStar. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Grand Angels, startups are often financed by Wakestream Ventures, Venture Investors, Biosciences Research and Commercialization Center (BRCC). The meaningful sponsors for the fund in investment in the same round are Wakestream Ventures, Biosciences Research and Commercialization Center (BRCC), eLab Ventures. In the next rounds fund is usually obtained by Wakestream Ventures, eLab Ventures, Venture Investors.
The top activity for fund was in 2011. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund.
Investments analytics
Analytics
- Total investments
- 26
- Lead investments
- 3
- Exits
- 3
- Rounds per year
- 1.37
- Follow on index
- 0.27
- Investments by industry
- Biotechnology (12)
- Health Care (9)
- Software (7)
- Medical Device (5)
- Life Science (5) Show 34 more
- Investments by region
-
- United States (26)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 0.85
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Blue Medora | 29 Jun 2015 | Software, Analytics, Enterprise Software, Cloud Computing | Early Stage Venture | 4M | United States, Michigan, Grand Rapids |
| Ripple Science | 29 Sep 2020 | Software, Health Care, SaaS, Clinical Trials | Seed | United States, Ann Arbor, Michigan |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.